Probiotics in the intensive care unit

Current Opinion in Critical Care

Volumn 15, Issue 2, 2009, Pages 144-148

  Morrow, Lee E ^a,b  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hospital acquired infection; Nutrition; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; METRONIDAZOLE; PREBIOTIC AGENT; PROBIOTIC AGENT; VANCOMYCIN; YOGHURT;

ACUTE PANCREATITIS; ANTIBIOTIC ASSOCIATED DIARRHEA; BIFIDOBACTERIUM BIFIDUM; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE INFECTION; CRITICALLY ILL PATIENT; DEVICE INFECTION; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; INFECTION; INTENSIVE CARE UNIT; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; METHODOLOGY; MORTALITY; MULTIPLE ORGAN FAILURE; PANCREATITIS; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS; PROBIOTICS;

EID: 67749130932     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283252d2d     Document Type: Review

References (31)

1. Cremonini F, Di Caro S, Nista EC, et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002; 16:1461-1467.
2. D'Souza AL, Rajkumar C, Cooke J, et al. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002; 324:1361.
3. Johnson BC, Supina AL, Vohra S. Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. CMAJ 2006; 175:377-383.
4. Szajewska H, Ruszczyski M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 2006; 149:367-372.
5. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101:812-822.
6. Hickson M, D'Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomized double blind placebo controlled trial. BMJ 2007; 335:80.
7. Wenus C, Goll R, Loken EB, et al. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. Eur J Clin Nutr 2008; 62:299-301.
8. Fernandez A, Anana G, Friedenberg F. Factors associated with failure of metronidazole in Clostridium difficile-associated disease. J Clin Gastroenterol 2004; 38:414-418.
9. Musher DM, Aslam S, Logan N, et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005; 40:1586-1590.
10. Pepin J, Alary ME, Valiquette L, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec. Clin Infect Dis 2005; 40:1591-1597.
11. Zar FA, Bakkanagari R, Moorthi MLST, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007; 45:302-307.
12. Dendukuri N, Costa V, McGregor M, et al. The use of probiotics in the prevention and treatment of Clostridium difficile-associated diarrhea. http://www.mcgill.ca/files/tau/PROBIOTICS-Report-5Final.pdf. [Accessed 15 November 2008].
13. Plummer S, Weaver MA, Harris JC, et al. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol 2004; 7:59-62.
14. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebocontrolled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994; 271:1913-1918.
15. Surawicz CM, McFarland LV, Greenberg RN, et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000; 31:1012-1017.
16. Wullt M, Hagslatt ML, Odenholt I. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand J Infect Dis 2003; 35:365-367.
17. Lawrence SJ, Korzenik JR, Mundy LM. Probiotics for recurrent Clostridium difficile disease. J Med Microbiol 2005; 54:905-906.
18. Besselink MGH, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebocontrolled trial. Lancet 2008; 371:651-659. This multicenter, randomized controlled trial is one of the largest and best designed studies of probiotic therapy for any indication. Despite preliminary results from animal studies and pilot data in humans, probiotic administration to patients with severe acute pancreatitis resulted in increased mortality.
19. Sun S, Yang K, He X, et al. Probiotics in patients with severe acute pancreatitis: a meta-analysis. Langenbecks Arch Surg 2008; 394:171-177.
20. Gluck U, Gebbers JO. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and b-hemolytic streptococci). Am J Clin Nutr 2003; 77:517-520.
21. Forestier C, Guelon D, Cluytens V, et al. Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Crit CareV 12 2008; R69. This study demonstrates the effects of probiotics on colonization with a problematic respiratory pathogen and demonstrates how those microbiologic findings translate into clinical results.
22. McNabb B, Isakow W. Probiotics for the prevention of nosocomial pneumonia: current evidence and opinions. Curr Opinion Pulm Med 2008; 14:168-175.
23. Kotzampassi K, Giamarellos-Bourboulis EF, Voudouris A, et al. Benefits of a symbiotic formula (Synbiotic 2000Forte) in critically ill trauma patients; early results of a randomized controlled trial. World J Surg 2006; 20:1848-1855.
24. Olah A, Belagyi T, Poto L, et al. Synbiotic control of inflammation and infection in severe acute pancreatitis; a prospective, randomized, double blind study. Hepatogastroenterology 2007; 54:590-594.
25. Spindler-Vesel A, Bengmark S, Vovk I, et al. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parenter Enteral Nutr 2007; 31:119-126.
26. Darouiche RO, Thornby JI, Cerra-Stewart C, et al. Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial. Clin Infect Dis 2005; 41:1531-1534.
27. US Food and Drug Administration. Food and drugs. Code of Federal Regulations title 21. http://www.access.gpo.gov/cgi-bin/cfrassemble.cgi? title=200821. [Accessed 14 November 2008].
28. Snydman DR. Safety of probiotics. Clin Infect Dis 2008; 46:S104-S111. This article expands on the issues surrounding the safety of probiotics that are briefly discussed in the current manuscript.
29. Watkinson PJ, Barber VS, Dark P, et al. The use of pre, pro-, and synbiotics in adult intensive care unit patients: systemic review.Clin Nutr2007;26:182-192. This systematic review concisely summarizes the use of a variety of probiotic preparations in the ICU.
30. Wickens K, Black PN, Stanley TV, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008; 122:788-794.
31. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001; 134:657-662.